Indolent course of progressive multifocal leukoencephalopathy during natalizumab treatment in MS

Neurology. 2011 Feb 8;76(6):574-6. doi: 10.1212/WNL.0b013e31820b7644.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Female
  • Humans
  • Leukoencephalopathy, Progressive Multifocal / chemically induced*
  • Leukoencephalopathy, Progressive Multifocal / pathology*
  • Magnetic Resonance Imaging / methods
  • Magnetic Resonance Imaging / standards
  • Multiple Sclerosis / drug therapy*
  • Multiple Sclerosis / pathology*
  • Natalizumab
  • Time Factors
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Natalizumab